Real-time enrollment status for this early rectal cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:32 PM UTC
| NCT Number | NCT07735624 |
| Recruiting Status | Recruiting |
| Condition | Early Rectal Cancer |
| Phase | PHASE2 |
| Target Enrollment | 16 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 31, 2026: Clinical trial NCT07735624 is currently recruiting participants. This phase2 study for early rectal cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07735624 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07735624 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.